Literature DB >> 10471409

Phosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damage.

P Chadebech1, L Brichese, V Baldin, S Vidal, A Valette.   

Abstract

Treatment of NIH-OVCAR-3 cells with paclitaxel, a microtubule-stabilizing agent, induces mitotic arrest and apoptosis, but also Bcl-2 phosphorylation. We report here that Bcl-2 phosphorylation precedes Bcl-2 down-regulation and that both events are closely associated with mitotic arrest, but are not sufficient for paclitaxel to trigger apoptosis. Indeed, when paclitaxel-treated cells were induced to exit mitosis in the presence of 2-aminopurine, Bcl-2 phosphorylation and Bcl-2 down-regulation were both inhibited. In contrast, when apoptosis was inhibited by a caspase inhibitor or Bcl-2 over-expression, Bcl-2 phosphorylation and down-regulation still occurred. Furthermore, we show that Bcl-2 is degraded in mitosis by the proteasome-dependent pathway since Bcl-2 down-regulation is inhibited by proteasome inhibitors such as MG132, Lactacystin and LLnL. Taken together these results indicate that mitotic spindle damage results in post-translational modifications of Bcl-2 by phosphorylation and degradation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471409     DOI: 10.1006/bbrc.1999.1291

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase.

Authors:  Fabio P S Santos; Hagop Kantarjian; David McConkey; Susan O'Brien; Stefan Faderl; Gautam Borthakur; Alessandra Ferrajoli; John Wright; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-08

2.  Amitozyn impairs chromosome segregation and induces apoptosis via mitotic checkpoint activation.

Authors:  Bastien Hermant; Bastien Herman; Aldrian Gudrun; Anatoly I Potopalsky; Jadwiga Chroboczek; Sergey O Tcherniuk
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

3.  The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.

Authors:  Gonzalo Sequeira; Silvia I Vanzulli; Paola Rojas; Caroline Lamb; Lucas Colombo; Maria May; Alfredo Molinolo; Claudia Lanari
Journal:  Oncotarget       Date:  2014-05-30

4.  Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1).

Authors:  Nadia Wahab; Dimity Cox; Abigail Witherden; Roger M Mason
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.